GEIST:UPC Searchengine

UPC_CFI_1/2023

Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH

Datum
2023-08-24
Kammer
Munich (DE) Central Division - Section
Verfahrensart
Preliminary objection
Sprache
EN

Metadaten

Fall-IDUPC_CFI_1-2023-d3f2c9973f8e
Aktenzeichen
RegisterzeichenUPC_CFI_1/2023
EntscheidungsreferenzORD_560432/2023
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 15

1 Central Division (Section Munich) UPC_CFI_1/2023 Order rejecting a Preliminary Objection of the Court of First Instance of the Unified Patent Court delivered on 24/08/2023 APPLICANT/S 1) Amgen, Inc., One Amgen Center Drive, CA 91320-1799 - Thousand Oaks, US Represented by Michael Eder RESPONDENT/S 1) Sanofi-Aventis Deutschland GmbH Brüningstrasse 50 - 65926 - Frankfurt - DE Represented by Daniel Wise 2) Sanofi-Aventis Groupe 82 Avenue Raspail - 94250 - Gentilly - FR Represented by Daniel Wise 3) Sanofi Winthrop Industrie S.A. 82 Avenue Raspail - 94250 - Gentilly - FR Represented by Daniel Wise 2 RELEVANT PROCEEDING PARTIES 1) Sanofi-Aventis Deutschland GmbH (Claimant) - Brüningstrasse 50 - 65926 - Frankfurt - DE Represented by Daniel Wise 2) Sanofi-Aventis Groupe (Claimant) - 82 Avenue R ...